InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（11 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
11
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Szot Matthew K, 首席财务官. Director active across 5 companies, notably S&W Seed Co. Aggregated, 19 reports have been published. Breakdown: 1 buy · 11 sells. Total volume traded: €175k. History available since 1 October 2021. The latest transaction was filed on 29 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Szot Matthew K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
9,933 股@ US$6.9736.3% 占其流量Common StockSEC:0001213900-25-127110:0
4 股@ US$1.52100.0% 占其流量Common stockSEC:0001493152-25-026483:0
1 股@ US$2.75100.0% 占其流量Common StockSEC:0001628280-25-052557:0
1,800 股@ US$13.9948.6% 占其流量Common StockSEC:0001213900-25-103147:0
1,800 股@ US$13.9948.5% 占其流量Common StockSEC:0001213900-25-103147:1
1,693 股@ US$13.9919.8% 占其流量Common StockSEC:0001213900-25-098718:0
107 股@ US$13.992.9% 占其流量Common StockSEC:0001213900-25-097178:0
100 股@ US$14.001.4% 占其流量Common StockSEC:0001213900-25-094804:0
1,500 股@ US$13.995321.6% 占其流量Common StockSEC:0001213900-25-092558:0
1,600 股@ US$13.99530.1% 占其流量Common StockSEC:0001213900-25-082821:0
50,000 股0Common StockSEC:0001213900-23-004883:0
14,474 股@ US$0.95100.0% 占其流量Common StockSEC:0001493152-22-015909:0
标准退出：2022年8月30日 (T+90)
7,490 股0Common StockSEC:0001209191-21-059957:0
1,496 股@ US$2.56100.0% 占其流量Common StockSEC:0001209191-21-059050:0
1,040 股Common StockSEC:0001209191-21-045457:0
4,722 股Common StockSEC:0001249155-16-000047:0
1,931 股Common StockSEC:0001249155-16-000047:1
2,917 股Common StockSEC:0001249155-16-000047:2
1,100 股Common StockSEC:0001249155-16-000047:3
19 条申报中的 19 条
About Szot Matthew K
Szot Matthew K is Chief Financial Officer. He has filed 19 disclosures in total, and among the most recent filings available, the transactions are mainly disposals, with EUR 12,906 in purchases and EUR 162,187 in sales between 2016-01-05 and 2025-12-31. He is listed as Chief Financial Officer at Cadrenal Therapeutics, Inc., EVP Finance & Admin and CFO at S&W Seed Co, and Director at INVO Fertility, Inc., SenesTech, Inc. and INVO Bioscience, Inc.
